Alpha tocopherol use in the management of diabetic cardiomyopathy: lessons learned from randomized clinical trials

Journal of Diabetes and its Complications

Volumn 24, Issue 4, 2010, Pages 286-288

  Celik, Turgay ^a   Yuksel, Cagdas ^b   Iyisoy, Atila ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Sarikamis Army District Hospital Turkey   (Turkey)

Author keywords

Alpha tocopherol; Diabetes mellitus; Diabetic cardiomyopathy; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; PLACEBO; RETINOL;

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETIC CARDIOMYOPATHY; GENETIC POLYMORPHISM; HEART FAILURE; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; DIABETIC CARDIOMYOPATHIES; HEART FAILURE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77953020912     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2009.02.005     Document Type: Article

References (22)

1. Asbun J., and Villarreal F.J. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. Journal of American College of Cardiology 47 (2006) 693
2. Ashrafian H., Frenneaux M.P., and Opie L.H. Metabolic mechanisms in heart failure. Circulation 116 (2007) 434
3. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., and Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. JAMA 297 (2007) 842-857
4. Brown B.G., Zhao X.Q., Chait A., Fisher L.D., Cheung M.C., Morse J.S., Dowdy A.A., Marino E.K., Bolson E.L., Alaupovic P., Frohlich J., and Albers J.J. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. New England Journal of Medicine 345 (2001) 1583-1592
5. Boudina S., and Abel E.D. Diabetic cardiomyopathy revisited. Circulation 115 (2007) 3212-3223
6. Bowry V.W., Ingold K.U., and Stocker R. Vitamin E in human low-density lipoproteins: When and how this antioxidant becomes a pro-oxidant. Biochemical Journal 288 (1992) 341-344
7. Bucala R., Tracey K.J., and Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. Journal of Clinical Investigation 87 (1991) 432-438
8. Galderisi M., Anderson K.M., Wilson P.W., and Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study). American Journal of Cardiology 68 (1991) 85-89
9. Johnstone M.T., Creager S.J., Scales K.M., Cusco J.A., Lee B.K., and Creager M.A. Impaired endothelium-dependent vasodilatation in patients with insulin-dependent diabetes mellitus. Circulation 88 (1993) 2510-2516
10. Keith M., Geranmayegan A., Sole M.J., Kurian R., Robinson A., Omran A.S., and Jeejeebhoy K.N. Increased oxidative stress in patients with congestive heart failure. Journal of the American College Cardiology 31 (1998) 1352-1356
11. Keith M.E., Jeejeebhoy K.N., Langer A., Kurian R., Barr A., O'Kelly B., and Sole M.J. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. American Journal of Clinical Nutrition 73 (2001) 219-224
12. Lonn E., Bosch J., Yusuf S., Sheridan P., Pogue J., Arnold J.M., Ross C., Arnold A., Sleight P., Probstfield J., Dagenais G.R., and HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: A randomized controlled trial. Journal of the American Medical Association 293 (2005) 1338-1347
13. Marchioli R., Levantesi G., Macchia A., Marfisi R.M., Nicolosi G.L., Tavazzi L., Tognoni G., Valagussa F., and GISSI-Prevenzione Investigators. Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial. Journal of Cardiovascular Medicine (Hagerstown) 7 (2006) 347-350
14. McMurray J., Chopra M., Abdullah I., Smith W.E., and Dargie H.J. Evidence of oxidative stress in chronic heart failure in humans. European Heart Journal 14 (1993) 1493-1498
15. Miller E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., and Guallar E. Meta-analysis: High dosage vitamin E supplementation may increase all cause mortality. Annals of Internal Medicine 142 (2005) 37-46
16. Rodrigues B., Cam M.C., and McNeill J.H. Myocardial substrate metabolism: Implications for diabetic cardiomyopathy. Journal of Molecular and Cellular Cardiology 27 (1995) 169-179
17. Scognamiglio R., Avogaro A., Casara D., Crepaldi C., Marin M., Palisi M., Mingardi R., Erle G., Fasoli G., and Dalla Volta S. Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus. Journal of the American College Cardiology 31 (1998) 404-412
18. Shirpoor A., Salami S., Khadem-Ansari M.H., Ilkhanizadeh B., Pakdel F.G., and Khademvatani K. Cardioprotective effect of vitamin E: Rescues of diabetes-induced cardiac malfunction, oxidative stress, and apoptosis in rat. Journal of Diabetes and Its Complications (2008, April) (Electronic publication ahead of print)
19. Stone P.H., Muller J.E., Hartwell T., York B.J., Rutherford J.D., Parker C.B., Turi Z.G., Strauss H.W., Willerson J.T., Robertson T., et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. Journal of the American College Cardiology 14 (1989) 49-57
20. Tousoulis D., Antoniades C., Vassiliadou C., Toutouza M., Pitsavos C., Tentolouris C., Trikas A., and Stefanadis C. Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure. European Journal Heart Failure 7 (2005) 1126-1132
21. Yoon Y.S., Uchida S., Masuo O., Cejna M., Park J.S., Gwon H.C., Kirchmair R., Bahlman F., Walter D., Curry C., Hanley A., Isner J.M., and Losordo D.W. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: Restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 111 (2005) 2073-2085
22. Zarich S., and Nesto R. Diabetic cardiomyopathy. American Heart Journal 118 (1989) 1000-1012